125 related articles for article (PubMed ID: 14576465)
1. Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers.
Tsou AP; Chuang YC; Su JY; Yang CW; Liao YL; Liu WK; Chiu JH; Chou CK
J Biomed Sci; 2003; 10(6 Pt 1):625-35. PubMed ID: 14576465
[TBL] [Abstract][Full Text] [Related]
2. [The imprinting status of genetic imprinted gene PEG10 in human hepatocellular carcinomas].
Gao Y; Zhang HD; Lin JS; Zhang MP; Zhang RG
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):894-9. PubMed ID: 21205473
[TBL] [Abstract][Full Text] [Related]
3. PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma.
Wang C; Xiao Y; Hu Z; Chen Y; Liu N; Hu G
FEBS Lett; 2008 Aug; 582(18):2793-8. PubMed ID: 18625225
[TBL] [Abstract][Full Text] [Related]
4. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.
Ip WK; Lai PB; Wong NL; Sy SM; Beheshti B; Squire JA; Wong N
Cancer Lett; 2007 Jun; 250(2):284-91. PubMed ID: 17126992
[TBL] [Abstract][Full Text] [Related]
5. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
Jie X; Lang C; Jian Q; Chaoqun L; Dehua Y; Yi S; Yanping J; Luokun X; Qiuping Z; Hui W; Feili G; Boquan J; Youxin J; Jinquan T
Oncogene; 2007 Aug; 26(39):5741-51. PubMed ID: 17369855
[TBL] [Abstract][Full Text] [Related]
6. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
Shyu YC; Lee TL; Lu MJ; Chen JR; Chien RN; Chen HY; Lin JF; Tsou AP; Chen YH; Hsieh CW; Huang TS
J Transl Med; 2016 Jul; 14(1):200. PubMed ID: 27370270
[TBL] [Abstract][Full Text] [Related]
7. Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1.
Okabe H; Satoh S; Furukawa Y; Kato T; Hasegawa S; Nakajima Y; Yamaoka Y; Nakamura Y
Cancer Res; 2003 Jun; 63(12):3043-8. PubMed ID: 12810624
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma.
Tsou AP; Yang CW; Huang CY; Yu RC; Lee YC; Chang CW; Chen BR; Chung YF; Fann MJ; Chi CW; Chiu JH; Chou CK
Oncogene; 2003 Jan; 22(2):298-307. PubMed ID: 12527899
[TBL] [Abstract][Full Text] [Related]
9. Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.
Bang H; Ha SY; Hwang SH; Park CK
Cancer Res Treat; 2015 Oct; 47(4):844-52. PubMed ID: 25687862
[TBL] [Abstract][Full Text] [Related]
10. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
11. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.
Tsuji K; Yasui K; Gen Y; Endo M; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Cancer Genet Cytogenet; 2010 Apr; 198(2):118-25. PubMed ID: 20362226
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
13. PEG10 is a c-MYC target gene in cancer cells.
Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
[TBL] [Abstract][Full Text] [Related]
14. A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21.
Ono R; Kobayashi S; Wagatsuma H; Aisaka K; Kohda T; Kaneko-Ishino T; Ishino F
Genomics; 2001 Apr; 73(2):232-7. PubMed ID: 11318613
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
16. [MiR-122 regulates the expression of PEG10 in hepatoma cell lines].
Chang Y; He XX; Li PY; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):288-91. PubMed ID: 20460050
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling and identification of novel genes in hepatocellular carcinomas.
Graveel CR; Jatkoe T; Madore SJ; Holt AL; Farnham PJ
Oncogene; 2001 May; 20(21):2704-12. PubMed ID: 11420682
[TBL] [Abstract][Full Text] [Related]
19. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.
Kainz B; Shehata M; Bilban M; Kienle D; Heintel D; Krömer-Holzinger E; Le T; Kröber A; Heller G; Schwarzinger I; Demirtas D; Chott A; Döhner H; Zöchbauer-Müller S; Fonatsch C; Zielinski C; Stilgenbauer S; Gaiger A; Wagner O; Jäger U
Int J Cancer; 2007 Nov; 121(9):1984-1993. PubMed ID: 17621626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
